http://www.pmlive.com/pharma_news/msd_probed_by_uk_for_blocking_remicade_biosimilars_1194261
http://www.nature.com/news/tissue-independent-cancer-drug-gets-fast-track-approval-from-us-regulator-1.22054
http://www.inquisitr.com/4243613/merck-co-gain-fda-approval-for-pembrolizumab-a-groundbreaking-new-cancer-medication/
http://www.medscape.com/viewarticle/880537
http://www.cambridge-news.co.uk/business/technology/amazing-flexible-displays-can-made-13086195
http://www.military-technologies.net/2017/05/24/sun-pharma-announces-us-fda-filing-acceptance-of-biologics-license-application-bla-for-tildrakizumab-3/
http://www.military-technologies.net/2017/05/24/sun-pharma-announces-us-fda-filing-acceptance-of-biologics-license-application-bla-for-tildrakizumab-2/
http://www.military-technologies.net/2017/05/24/merck-manuals-survey-americans-with-digestive-discomfort-take-treatment-into-their-own-hands/
http://www.prnewswire.com/news-releases/merck-manuals-survey-americans-with-digestive-discomfort-take-treatment-into-their-own-hands-300463011.html
http://www.pmlive.com/pharma_news/keytruda_is_first_fda-approved_drug_for_molecular_indication_1194214
http://www.proactiveinvestors.co.uk/columns/guardian-cfds-newspaper-briefing/27830/in-the-papers-ryanair-jaguar-land-rover-rbs-apple-27830.html
http://www.rttnews.com/2778143/mrk-s-keytruda-scores-another-fda-nod-nbix-disappoints-sbph-achieves-it.aspx
http://www.military-technologies.net/2017/05/24/merck-announces-third-quarter-2017-dividend-2/
http://www.military-technologies.net/2017/05/25/latin-america-veterinary-vaccines-market-is-poised-to-reach-726-87-million-by-2020-from-5306-million-in-2015-at-a-cagr-of-6-2/
http://www.dailymail.co.uk/~/article-4538156/index.html
http://www.prnewswire.com/news-releases/sun-pharma-announces-us-fda-filing-acceptance-of-biologics-license-application-bla-for-tildrakizumab-300463108.html
https://www.scientificamerican.com/article/fda-clears-first-cancer-drug-based-on-genetics-of-disease-not-tumor-location/
http://www.military-technologies.net/2017/05/24/sun-pharma-announces-us-fda-filing-acceptance-of-biologics-license-application-bla-for-tildrakizumab/
https://qz.com/990246/the-fda-just-approved-a-drug-that-targets-cancer-by-genetic-marker-not-body-parts/
http://www.xconomy.com/national/2017/05/23/fda-landmark-nod-cancer-drug-to-match-tumor-genes-not-tissue-type/
http://medcitynews.com/2017/05/fda-approves-cancer-drug-biomarker-not-tissue/
http://www.webmd.com/cancer/news/20170524/fda-oks-first-cancer-drug-by-genetic-type-not-organ-of-origin
http://www.thedailybeast.com/articles/2017/05/24/pro-trumpcare-republicans-owned-millions-in-health-care-stock
http://www.ssuchronicle.com/2017/05/24/new-employer-guide-from-staywell-offers-insight-into-the-changing-world-of-incentives/
https://www.engadget.com/2017/05/24/fda-merck-keytruda-cancer-biomarker/
http://www.upi.com/Health_News/2017/05/24/FDA-approves-cancer-drug-based-on-genetic-type-not-organ-of-origin/2391495644008/
https://www.technologyreview.com/s/607927/drug-is-first-to-treat-cancer-based-on-genetics-not-location/
http://www.military-technologies.net/2017/05/24/mary-m-gallagher-seniorlink-senior-vice-president-and-chief-marketing-officer-named-one-of-the-2017-pm360-elite-100/
http://www.military-technologies.net/2017/05/24/dental-drug-industry-analysis-prediction-to-2022-by-region-type-and-technology/
http://www.business-standard.com/content/b2b-pharma/us-fda-accepts-application-of-sun-pharma-s-partner-merck-for-tildrakizumab-117052400558_1.html
http://www.military-technologies.net/2017/05/24/travel-vaccines-market-set-to-grow-exponentially-during-the-forecast-2021/
http://www.military-technologies.net/2017/05/24/drugs-for-sinusitis-market-report-2017-top-countries-manufacturers-types-and-applications/
http://www.military-technologies.net/2017/05/25/vitamin-deficiency-treatment-market-is-expected-to-continue-flourishing-in-developed-and-developing-regions-of-world-2022/
http://www.military-technologies.net/2017/05/25/vitamin-deficiency-treatment-market-is-expected-to-continue-flourishing-in-developed-and-developing-regions-of-world-2022-2/
http://www.military-technologies.net/2017/05/25/malignant-glioma-market-global-market-snapshot-by-2022-persistence-market-research/
http://www.military-technologies.net/2017/05/25/europe-veterinary-vaccines-market-is-poised-to-reach-2540-82-million-by-2020-from-1993-64-million-in-2015-at-a-cagr-of-4-97/
http://www.military-technologies.net/2017/05/25/pulmonary-drugs-market-research-report-forecast-to-2024/
http://www.military-technologies.net/2017/05/24/new-pappas-capital-fund-makes-first-investment/
http://www.prnewswire.com/news-releases/new-pappas-capital-fund-makes-first-investment-300463377.html
http://www.marketwatch.com/story/new-pappas-capital-fund-makes-first-investment-2017-05-24
http://www.military-technologies.net/2017/05/24/lifestyle-drugs-market-set-to-witness-an-uptick-during-2017-2025-persistence-market-research/
http://politi.co/2qjAs26
http://www.business-standard.com/article/news-ians/usfda-accepts-biological-license-application-from-sun-pharma-117052401059_1.html
http://www.sify.com/news/usfda-accepts-biological-license-application-from-sun-pharma-news-others-rfyrEejjfcbhd.html
http://www.zonebourse.com//actualite-bourse/MERCK-CO-la-FDA-valide-de-nouvelles-indications-pour-le-Keytruda--24478570/
http://www.flicksandbits.com/credence-research-industry-analysis-report-bovine-respiratory-disease-treatment-market-2017/
http://www.military-technologies.net/2017/05/24/global-immuno-oncology-market-is-expected-to-witness-significant-growth-of-us-27846-3-million-by-2025/
http://www.business-standard.com/article/news-cm/sun-pharma-intimates-of-acceptance-of-regulatory-filings-for-tildrakizumab-117052400265_1.html
http://www.military-technologies.net/2017/05/24/european-contraceptive-market-projected-to-be-at-7-76-billion-by-2021/
http://www.dnaindia.com/business/report-us-fda-accepts-application-for-psoriasis-drug-sun-pharma-2449135
http://www.emailwire.com/release/386659-AsiaPacific-Companion-Animal-Healthcare-Market-estimated-to-reach-276-Billion-by-the-end-of-2021.html
http://www.emailwire.com/release/386758-Recombinant-Protein-Market-Worldwide-Overview-by-Major-Countries-Growth-and-Forecast-To-2021.html
http://www.emailwire.com/release/386771-European-Bovine-Respiratory-Disease-Treatment-Market-shows-rapid-growth-with-a-high-CAGR-of-205.html
http://www.emailwire.com/release/386772-Europe-Biomarkers-market-driven-by-its-importance-in-clinical-trials-and-drug-discovery.html
http://www.emailwire.com/release/386780-The-Europe-Cancer-Immunotherapy-Market-worth-USD-2341-Billion-by-the-end-of-2021.html
http://www.military-technologies.net/2017/05/24/europe-biopharmaceuticals-market-is-worth-usd-37-12-billion-in-2016/
http://www.military-technologies.net/2017/05/24/2021-global-veterinary-vaccines-market-competition-status-and-forecast-market-size-by-players-regions-type-application/
http://www.military-technologies.net/2017/05/24/asthma-market-h1-2017-covering-companies-illuminated-by-new-report/
http://www.military-technologies.net/2017/05/24/north-america-veterinary-vaccines-market-is-poised-to-reach-2171-69-million-by-2020-from-17026-million-in-2015-at-a-cagr-of-4-93/
http://www.military-technologies.net/2017/05/24/asia-pacific-veterinary-vaccines-market-is-expected-to-reach-a-value-of-1303-27-million-by-2021/
http://www.military-technologies.net/2017/05/24/middle-east-and-africa-veterinary-vaccines-market-is-poised-to-reach-455-17-million-by-2020-from-348-61-million-in-2015-at-a-cagr-of-5-48/
http://www.ssuchronicle.com/2017/05/24/systemic-antibiotic-sulfonamide-combination-pharmaceuticals-market-global-industry-analysis-size-share-growth-trends-and-forecast-2016-2023/
http://www.military-technologies.net/2017/05/24/systemic-antibiotic-sulfonamide-combination-pharmaceuticals-market-global-industry-analysis-size-share-growth-trends-and-forecast-2016-2023/
http://www.military-technologies.net/2017/05/24/pipeline-analysis-of-herpes-zoster-shingles-and-therapeutic-development-in-h1-2017/
http://www.reuters.com/article/usa-congress-mcconnell-fda-idUSL1N1IQ21U
http://www.dailyexcelsior.com/us-fda-accepts-application-for-psoriasis-drug-sun-pharma/
http://www.dailymail.co.uk/~/article-4538714/index.html
http://www.business-standard.com/article/companies/sun-pharma-to-create-drug-used-for-treatment-of-psoriasis-gets-usfda-s-nod-117052400304_1.html
http://www.livemint.com/Industry/UTrDtZBSi9DFMfvwzTtpeJ/USFDA-accepts-application-for-psoriasis-drug-Sun-Pharma.html
http://www.moneycontrol.com/news/business/us-fda-accepts-application-for-psoriasis-drug-sun-pharma-2287441.html
